Intellectual Asset Management Recognizes Foley Attorneys in 2021 Patent 1000 Guide
July 15, 2021
Intellectual Asset Management
Intellectual Asset Management (IAM) has recognized 15 Foley attorneys in the 10th edition of its Patent 1000 – The World’s Leading Patent Professionals guide. Additionally, the firm was recognized for offices and practices, including the District of Columbia (prosecution), Milwaukee and Detroit.
The Foley attorneys recognized include:
- Scott Anderson, prosecution
- Courtenay Brinckerhoff, prosecution
- Jeffrey Costakos, litigation
- Jeanne Gills, litigation
- Jeffrey Gundersen, prosecution
- John Lanza, prosecution
- Matthew Lowrie, litigation
- Stephen Maebius, prosecution, transactions
- Christopher McKenna, prosecution
- George Quillin, prosecution
- Michele Simkin, prosecution
- Gary Solomon, prosecution
- Eric Sophir, prosecution
- Marcus Sprow, prosecution
- Joseph Ziebert, prosecution
The Patent 1000 – The World’s Leading Patent Professionals guide is compiled by a team of researchers from IAM magazine based on more than 1,800 interviews with private practice and in-house professionals regarding the full range of patent services. For more information about IAM and Patent 1000, please visit their website.
People
Related News
June 10, 2025
In the News
Lynn Gandhi Sheds Light on Supreme Court Tax Ruling
Foley partner Lynn Gandhi commented in the Bloomberg Tax article "High Court’s Catholic Charities Case to Go Beyond Unemployment," sharing insight on the implications of the recent Supreme Court ruling in a tax case.
June 10, 2025
In the News
James McFall Joins Iconic Athletes and Leaders in Launch of Stanford Football Alumni United
Foley & Lardner LLP is proud to announce that partner James Carlos McFall is a founding member of Stanford Football Alumni United (SFAU), a newly formed coalition of former players and leaders committed to supporting Stanford Football’s continued growth and national competitiveness.
June 6, 2025
In the News
David Rosen Comments on FDA, Compounder Conflict Over Drug Shortages
Foley & Lardner LLP partner David Rosen highlighted the U.S. Food and Drug Administration's drug shortage list in the BioSpace article, "Post-Chevron Legal Battles: Three Key Cases to Watch."